Aquaculture biotech group Benchmark raises $50 million to launch new sealice treatment

Some directors have subscribed to buy shares in the offering.

Benchmark Chairman Peter George in the official opening of the Salmobreed facility. — Benchmark Chairman Peter George in the official opening of the Salmobreed facility.Photo: Bent-Are Jensen

Demi Korban

Benchmark Peter George London Stock Exchange Sea lice

Published 30 January 2020, 09:00Updated 30 January 2020, 13:26